News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Judge Rejects Myriad Genetics, Inc. Patents on Genes
March 30, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WSJ -- In a court ruling likely to be followed closely by the medical industry, a federal judge in Manhattan on Monday struck down some of a company's patents on two genes linked to breast and ovarian cancers.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
·
2 min read
·
Tristan Manalac
Government
Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive
January 23, 2026
·
3 min read
·
Tristan Manalac
Rare diseases
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way
January 23, 2026
·
3 min read
·
Heather McKenzie
Vaccines
ACIP Chair Questions Polio Vaccines, Values Individual Choice Over Public Benefit
January 23, 2026
·
2 min read
·
Tristan Manalac